BibTeX
CSL-JSON
MLA
Harvard
Paclitaxel/carboplatin with or without sorafenib in the first-line treatment of patients with stage III/IV epithelial ovarian cancer: a randomized phase II study of the Sarah Cannon Research Institute
release_og6fpj5b2jg2vk4br6sns5e4dm
by
John D. Hainsworth, Dana S. Thompson, John A. Bismayer, Victor G. Gian, William M. Merritt, Robert C. Whorf, Lindsey H. Finney, B. Stephens Dudley
Archived Files and Locations
application/pdf 380.5 kB
file_cwn2xdijnvgorcc5opomygcjka
|
europepmc.org (repository) web.archive.org (webarchive) |
Read Archived PDF
Preserved and Accessible
Container Metadata
Open Access Publication
In DOAJ
In ISSN ROAD
In Keepers Registry
ISSN-L:
Open Access Publication
In DOAJ
In ISSN ROAD
In Keepers Registry
ISSN-L:
2045-7634
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
access all versions, variants, and formats of this works (eg, pre-prints)
Cite This
Lookup Links
oaDOI/unpaywall (OA fulltext)
Crossref Metadata (via API)
Worldcat
SHERPA/RoMEO (journal policies)
wikidata.org
CORE.ac.uk
Semantic Scholar
Google Scholar
Crossref Metadata (via API)
Worldcat
SHERPA/RoMEO (journal policies)
wikidata.org
CORE.ac.uk
Semantic Scholar
Google Scholar